Latest News Archive
Please select Category, Year, and then Month to display items
22 September 2021
|
Story Michelle Nöthling
|
Photo Supplied
Annemarie Le Roux.
“I love working with children.” This is one of the first things Annemarie le Roux mentions when asked to describe herself. This love for children propelled Annemarie into the field of education and she graduated in 2006 with a BEd in Foundation Phase at the UFS. Annemarie immediately immersed herself in the Deaf community, enriching the lives of children at the Thiboloha School for the Deaf in Qwaqwa and the De la Bat School for the Deaf in Worcester.
The academic world enticed Annemarie back to the University of the Free State (UFS) and she was appointed as a junior lecturer in the Department of South African Sign Language (SASL) and Deaf Studies in 2013. Going from strength to strength, Annemarie completed her master’s degree in SASL in 2019, and published an
article earlier this year that she co-wrote with Marga Stander. In this article, they found that SASL “has become an increasingly popular language that hearing university students want to learn as a second language” and subsequently explored different teaching methods used for this emerging group of interested students.
Although now firmly established in academia, Annemarie is still committed to the practical application of SASL. “I am closely involved in student and community engagement through the
SIGNALS Sign Language student association that helps empower the Deaf community and South African Sign Language.” She also interprets for the Deaf community whenever she gets an opportunity, as well as for Deaf students in class and meetings.
On the importance of Sign Language and the recognition of the Deaf community in South Africa, Annemarie believes it will open greater opportunities for development. “More people will be able to learn SASL, and it might even become a subject in school for hearing children.”
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”